Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Omind Neurotechnologies has developed a commercialized suite of neuroscience-based digital tools that use gamification, AI-driven analytics, and validated scientific methods to assess and develop soft skills such as emotional intelligence, adaptability, resilience. Their solutions are used by over fifty large organizations to improve leadership performance and employee well-being. The company’s approach has been validated through eight years of R&D in partnership with leading research institutions. No traditional clinical trial results as it does not develop therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Omind Neurotechnologies.